目前对静脉静脉复原的管理
Daniele Giacoppo1, Placido Maria Mazzone1, Davide Capodanno1
1Division of Cardiology, Azienda Ospedaliero-Universitaria Policlinico "Rodolico-San Marco", Department of Surgery and Medical-Surgical Specialties, University of Catania, via Santa Sofia 78, 95124 Catania, Italy.
Journal of clinical medicine
|April 27, 2024
概括
静脉静脉复缩 (ISR) 治疗具有挑战性. 药物涂层气球和药物释放支架是有效的,但患者和病变的特点指导最佳策略选择,以获得更好的结果.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 血管生物学 血管生物学
背景情况:
- 静脉静脉复缩 (ISR) 是皮肤穿透冠状动脉干预 (PCI) 后目标病变衰竭的主要原因,具有显著的重血管化率.
- 由于复发风险和对治疗的不同反应,受患者和病变因素的影响,ISR治疗是复杂的.
- 血管内成像对于识别ISR基质和指导定制治疗方法至关重要.
研究的目的:
- 审查ISR的当代干预治疗策略.
- 评估关于ISR管理的随机试验的证据.
- 为ISR治疗的未来方向提供见解.
主要方法:
- 随机试验证据的全面评估.随机试验中的证据.
- 药物涂层气球 (DCB) 血管整形与药物排泄支架 (DES) 植入的分析.
- 评估辅助疗法,包括切割/得分气球,静脉内石和旋转性心脏切除术.
主要成果:
- 无论是DCB血管整形还是DES植入都是有效的独立治疗ISR.
- DCB避免了金属层,可能减少新极端增生症和长期风险.
- DES提供了机械优势和光效益,但重复支架可以促进ISR机制.
结论:
- 最佳的ISR治疗需要在DCB和DES之间进行患者和病变特定的选择.
- 辅助疗法可以提高ISR干预措施的有效性.
- 个性化治疗策略是改善ISR管理的长期结果的关键.
相关概念视频
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
169
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
169
01:26Peptic Ulcer Disease IV: Management
89
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
89